|
Dr. Muldoon conducts clinical research examining the interface of behavioral and biological risk factors for cardiovascular disease. Cardiovascular risk conveyed by hypertension, lipid disorders, insulin resistance and pre-clinical atherosclerosis are studied in relation to individual differences health behaviors (diet and exercise), cognition (attention, working memory, executive function, and impulsivity) and in mood (depression and anxiety). In addition, Dr. Muldoon has tested Interventions to treat or prevent hypertension, including prescribed pharmacotherapies, and nutritional supplements. His most recent work leverages e-health technologies to aid patients in self-management of their hypertension. He has lead or co-lead investigations using randomized and double-blind trial design, physiologic and ambulatory recordings, automated and bidirectional short-messaging systems, biomarker assessment, genomics and functional brain imaging. The majority of Dr. Muldoon’s research funding has come from competitive grants awarded by the National Institutes of Health (US Public Health Service).
|